Home | News | Inhaled insulin launched in US

Inhaled insulin launched in US

Hoping to appeal to millions of needle-phobic diabetics, drugmakers Sanofi and Mannkind have launched Afrezza, an insulin that's inhaled, rather than injected.

Please login below to view content or register for a 4 week FREE Trial.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now